Experimental beneficial effect of rosuvastatin on burn wound healing in a rat model

Figure 1 Graphical presentation. A: C-reactive protein changes by rat group and day of sacrifice. The study group showed a significant and gradual decrease in C-reactive protein levels on later sacrifice days compared to the control and placebo groups (P < 0.01), confirming a reduction in the inflammatory response; B: Graphical presentation tumor necrosis factor-alpha changes by rat group and day of sacrifice. The study group showed a significant and gradual decrease in tumor necrosis factor-alpha levels on later sacrifice days compared to the control and placebo groups (P < 0.01), confirming a reduction in the inflammatory response; C: Graphical presentation interleukin-1β changes by rat group and day of sacrifice. The study group showed a significant and gradual decrease in interleukin-1β levels on later sacrifice days compared to the control and placebo groups (P < 0.01), confirming a reduction in the inflammatory response; D: Graphical presentation interleukin-6 changes by rat group and day of sacrifice. The study group showed a significant and gradual decrease in interleukin-6 levels on later sacrifice days compared to the control and placebo groups (P < 0.01), confirming a reduction in the inflammatory response; E: Graphical presentation burn wound size changes by rat group and day of sacrifice. The study group showed a significant and gradual decrease in burn wound size on later sacrifice days compared to the control and placebo groups (P < 0.01), confirming a better healing process. CRP: C-reactive protein; TNF-α: Tumor necrosis factor-alpha; IL-1β: Interleukin-1β; IL-6: Interleukin-6.